Table 3: Antimalarial drugs ordered for treating infants under 6 months by prescribers.
| Variable | Subgroup | Number of prescribers | Percentage |
| Antimalarial drug used | Artemether-Lumefantrine | 33 | 37.9 |
| Artesunate-Amodiaquine | 30 | 41.4 | |
| Quinine | 10 | 11.5 | |
| IV artesunate | 3 | 3.4 | |
| Dihydroartemisinin-piperaquine | 1 | 1.1 | |
| IV artesunate + AL | 2 | 2.3 | |
| Quinine + IV artesunate | 2 | 2.3 | |
| Reasons for the choice of an antimalarial drug | Availability | 5 | 6.6 |
| Drug of choice | 11 | 14.5 | |
| First line drug | 5 | 6.6 | |
| Hospital protocol | 3 | 3.9 | |
| Minimal side effects | 6 | 7.9 | |
| NMCP* recommendation | 3 | 3.9 | |
| Safe and efficacious | 28 | 36.8 | |
| STG recommendation | 4 | 5.3 | |
| WHO recommendation | 7 | 9.2 | |
| Others | 4 | 5.3 |